Identify therapeutic opportunities that address the genetic, molecular, or cellular causes of kidney disease and prioritize programs based on scientific rationale, translational potential, patient need, competitive differentiation, technical feasibility, and probability of clinical success. Demonstrated expertise in kidney biology, renal physiology, nephrology drug discovery, or the molecular mechanisms of kidney disease with the ability to translate disease biology, human genetics, and translational evidence into therapeutic hypotheses and executable research plans.